More recently, paralleling increased circulating levels of FSH occurring at menopause, FSH/FSHR have been reported to likely play a role in highly prevalent pathologies such as obesity, osteoporosis, cardiovascular diseases [11], or Alzheimer’s disease [12,13]. Here, BRD2 is linked to obesity due to melanocortin 4 receptor deficiency.